EMA Authorised: Azarga (brinzolamide;timolol maleate) — Novartis Europharm Limited

View source ↗

Summary

EMA authorised Azarga, a fixed-dose combination of brinzolamide and timolol, for open-angle glaucoma and ocular hypertension; applicant: Novartis Europharm Limi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• Azarga (brinzolamide; timolol maleate)

Snippet

Status: Authorised. Therapeutic area: Glaucoma, Open-Angle;Ocular Hypertension. MAH: Novartis Europharm Limited. Decision date: 04/02/2026